Navigation Links
New Welsh 'Self-Test' to Cure Glaucoma, the Leading Cause of Preventable Blindness
Date:3/31/2008

MIAMI, March 31 /PRNewswire/ -- According to the World Health Organization, more than five million people, mostly elderly blacks, but many Latinos and a few elderly Whites with their Glaucoma family members, needlessly suffer horribly from total incurable Glaucoma-Blindness ("White-Canes"). Most lack the opportunity to get tested for Earlier Glaucoma before Glaucoma slowly robbed them of all their sight. Dr. Robert Welsh, a Rotarian, a world-renowned Eye Surgeon and a leading Medical Missionary can help prevent 80,000 new totally blind Glaucoma cases a year through administering his new unique invention: The Welsh Glaucoma "Self-Test," and the New Welsh "T.V. Self-Test for Earlier Glaucoma," on all USA T.V. Stations.

Dr. Welsh said, "Elderly blacks are nine times more gene prone to developing blinding Glaucoma than other population groups where the severe threat of new total blindness from chronic Glaucoma can run as high as 80,000 newly blind cases per year. Early Glaucoma diagnosis and treatment can be made by working with Pastors at black churches throughout America."

The Newest Welsh "Self-Test" for Earlier Glaucoma may be awkward, but is also accurate. It involves holding one hand over the opposite eye and then using the free hand for "Finger-Wiggling," testing motion nasally in the eye, staring laterally, to detect reduced or lost "Nose Side Side-Vision," called a 95% Glaucoma diagnostic "Nasal-Step" loss. Nasal Steps should be either 80% above 180-degrees or below 15%. No insurance pays for Gross-Field Testing. Most Glaucoma experts and Glaucoma advisors have almost zero experience in Gross-Field Testing.

The new Welsh "Self-Test" for Glaucoma can be administered and explained on all USA T.V. Stations as the new "Welsh T.V. Self-Test" for Earlier Glaucoma and also used in 13,000 US black churches with simple Self-Test instructions from their Pastors. Pastors can scan their elderly black congregation in five minutes after sermons or
'/>"/>

SOURCE Dr. Robert Welsh, MD-Eye
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Dr. Welsh Self-Test Diagnoses Glaucoma, the Leading Cause of Preventable- Blindness
2. Leading Epilepsy Advocates Propose Strategies to Heighten Treatment Expectations and Close Patient and Physician Communication Gaps
3. AutismOnline.org Partners With Leading Health Communications Firm for Support
4. NYU dental researchers find evidence of periodontal disease leading to gestational diabetes
5. Leading Health Groups Applaud Continued Efforts to Protect Public Health by Ending So-Called Theatrical Productions in Bars
6. Leading Autism Expert Kenneth A. Bock, M.D. Launches National Foundation to Provide Financial Assistance to Children with Autism, Allergies, Asthma and ADHD
7. Australias Leading Juice Company Launches Juice Blend with Marteks lifesDHA(TM)
8. Researchers develop a method to select eggs with the best chance of leading to successful pregnancy
9. Leading researchers honored for progress in cancer prevention, detection and treatment
10. Following School Suicide, National Childrens Charity Issues Tips and Free Resources to Help Prevent 3rd Leading Cause of Death Among Youth
11. Genta Announces Licensing Agreement for Worldwide Development and Commercialization of a Leading Oral Taxane, Tesetaxel

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...SHINGTON, Nov. 9 The Churchill C...Award For Leadership to J.W. "Bill" Marriott for h...ugh progressive free market practices and fosterin... Mr. Marriott will receive his award at a ceremony...ton D.C. Four Seasons Hotel. ,, "This is a tes...
(Date:11/9/2009)...elped men and women almost equally, study finds, ...he widely used clot-dissolving drug Plavix (clopid... analysis of major clinical trials has found. ,...in treating both men and women with this very impo...of cardiovascular thrombosis at New York Universit...
(Date:11/9/2009)...on of plans finds differences in mood despite simi...thDay News) -- Both a high-fat, low-carbohydrate d...at, high-carb diet appear to help people lose poun...d? Only the low-fat diets will result in long-term...Nov. 9 issue of Archives of Internal Medicine . ,...
(Date:11/9/2009)... Tomorrow may be too late when it...tion, according to TOPS Club, Inc. (Take Off Pound...anization. , (Vocus) Nove...omes to preventing or improving a diabetes conditi...Sensibly), the nonprofit weight-loss support organ...
(Date:11/9/2009)...BANON, Tenn., Nov. 9 Health Connec...nced it will host their inaugural Hospital O.R. an... at the Marriott Renaissance Hotel in Nashville, T...re than 100 hospital operating room directors and ...alth systems in the country. Some of the confirmed...
Breaking Medicine News(10 mins):Health News:J.W. 'Bill' Marriott to Receive Churchill Centre Award For Leadership 2Health News:No Gender Gap Found for Clot-Busting Drug 2Health News:No Gender Gap Found for Clot-Busting Drug 3Health News:To Feel Better, Low-Fat Diet May Be Best 2Health News:To Feel Better, Low-Fat Diet May Be Best 3Health News:Diabetes Prevention Is the Best Remedy, TOPS Medical Expert Says 2Health News:Diabetes Prevention Is the Best Remedy, TOPS Medical Expert Says 3Health News:Health Connect Partners Hosts Hospital O.R. & Surgery Center Conference 2
...al shows novel compound blocks enzyme triggering c...4 (HealthDay News) -- A drug designed to lessen mu... safety tests in humans. , The drug, known as KAI-...ervention (PCI). PCI is a set of procedures includ...
...reading of screening mammograms with computer-aide...ading and yields a higher sensitivity than the fir...o a study conducted by researchers at Charlotte Ra...onsisted of the mammogram being first read by sub-...
...echnique that combines bone marrow removal and inj...of new bone at targeted locations in the body, it ... in Tissue Engineering. , "This could radically c...gns Vignery , associate professor of orthopedics ...
...O(TM) Beverage Provides Refreshing Taste with Bene... International today,launches HIRO(TM) Super Fruit...its popular HIRO(TM) ready-to-drink noni-based bev...pe., HIRO Super Fruits Sparkling Black Currant is...
..., Feb. 14 Today, the Centers for,Disease Control ...sting,performed on occupied FEMA travel trailers. ... testified before the Committee on Homeland,Securi...associated with prolonged formaldehyde exposure ca...
...aeli scientist, Dr. Siegal Sadetzki, has found a l...f tumors. , Dr. Sadetzki, a physician, epidemiol...ed the results of a study recently in the American...rs of the salivary gland. , Those who used a cel...
Other Medicine News:Health News:Drug Cuts Muscle Damage After Heart Attack 2Health News:Single reader with CAD more efficient, yields fewer false positives, and possibly more sensitive 2Health News:Tahitian Noni International Expands HIRO(TM) Beverage Line With Super Fruits Sparkling Black Currant 2Health News:Thompson Demands Solution to Formaldehyde Trailer Crisis 2Health News:Cell phone-cancer link found by Tel Aviv University scientist 2
(Date:11/9/2009)...ION, N.J., Nov. 9 Unwavering from ...s, but recognizing today,s economic climate, Lutro...thetic laser systems, introduces the MOSAIC CO2, a...er $50,000. ,, The MOSAIC CO2 offers many of t...logy including scanning and stamping operation mod...
(Date:11/9/2009)... Nov. 9 Decision Resources, one of...or pharmaceutical and healthcare issues, finds tha... 2 (HER2) targeting therapies -- which include Roc...ayaku,s Tykerb/Tyverb -- were the highest-selling ...ptake of Herceptin and Tykerb/Tyverb and the expec...
(Date:11/9/2009)... Nov. 9 ARmark Authentication Tech...an alliance in the development and introduction of...ion technology that incorporates microscopic cover...ngs of solid oral dosage forms (SODFs) to prevent ...lusive rights to market ARmark,s micro-tags for ta...
Breaking Medicine Technology:Lutronic(R) Unleashes the New MOSAIC CO2 2Sales of HER2-Targeting Agents for Breast Cancer, Including Herceptin and Tykerb/Tyverb, Will Grow by 3.3 Percent Annually from 2008 to 2018 2ARmark Authentication Technologies, LLC and Colorcon, Inc. Announce Alliance 2ARmark Authentication Technologies, LLC and Colorcon, Inc. Announce Alliance 3Research breakthrough will lead to more accurate weather forecasts 13460 1Research breakthrough will lead to more accurate weather forecasts 13460 2Mental Activity Seems to Keep the Brain Vital 54005 1Mental Activity Seems to Keep the Brain Vital 54005 2The Sloane Clinic pioneers Ultherapy in Singapore 54003 1The Sloane Clinic pioneers Ultherapy in Singapore 54003 2The Sloane Clinic pioneers Ultherapy in Singapore 54003 3
...ntinues to anticipate CHMP opinion in the third qu...mission decision in the fourth ...Pharma, Inc.,(Nasdaq: IDMI ) today announced that...requested additional data analyses from the Phase ...o complete the additional data,analyses, respond t...
...ss., July 1 Echo Therapeutics,Inc. (OTC Bulletin ... a,clinical study of its Symphony(TM) Transdermal ... in patients with Type 1 and Type 2,diabetes. The ...ts of the,study in the third quarter of 2008. Echo...ts Prelude(TM) SkinPrep System, which incorporates...
Other Medicine Technology:IDM Pharma Provides Update on Mifamurtide (L-MTP-PE) Regulatory Status Following June Meeting of European Committee for Medicinal Products for Human Use (CHMP) 2IDM Pharma Provides Update on Mifamurtide (L-MTP-PE) Regulatory Status Following June Meeting of European Committee for Medicinal Products for Human Use (CHMP) 3IDM Pharma Provides Update on Mifamurtide (L-MTP-PE) Regulatory Status Following June Meeting of European Committee for Medicinal Products for Human Use (CHMP) 4IDM Pharma Provides Update on Mifamurtide (L-MTP-PE) Regulatory Status Following June Meeting of European Committee for Medicinal Products for Human Use (CHMP) 5Echo Therapeutics Initiates Clinical Study of Its Symphony(TM) Transdermal Continuous Glucose Monitoring System in Patients with Type 1 and Type 2 Diabetes 2Echo Therapeutics Initiates Clinical Study of Its Symphony(TM) Transdermal Continuous Glucose Monitoring System in Patients with Type 1 and Type 2 Diabetes 3
ALLEGRO Analyzer
RESTASIS®
LADARWave® Aberrometer
ZYMAR™ 2.5 mL
Medicine Products: